Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration U.S. Department of Health & Human Services
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health Care Concerns About HRSA
FY 2009 Budget Justification
 

Sickle Cell Service Demonstration Program

FY 2007
Actual
FY 2008
Enacted
FY 2009
Request
FY 2009 +/-
FY 2008
BA $2,180,000 $2,653,000 $2,184,000 -$469,000
FTE 2 2 2 ---

Authorizing Legislation -Section 712(c) of the American Jobs Creation Act of 2004.

FY 2009 Authorization $10,000,000

Allocation Method

  • Competitive grant/co-operative agreement
  • Contract

Program Description and Accomplishments
The Sickle Cell Service Demonstration Program was created in FY 2005 to develop systemic mechanisms for the prevention and treatment of Sickle Cell Disease, including the coordination of service delivery for individuals with Sickle Cell Disease; genetic counseling and testing; bundling of technical services related to prevention and treatment of Sickle Cell Disease; training of health professionals; and identifying and establishing other efforts related to the expansion and coordination of education, treatment, and continuity of care programs for individuals with Sickle Cell Disease. The four year plan for the Sickle Cell Service Demonstration Program charting the course of the program outlining objectives and priority areas has been developed. The priorities include:

  • Technical assistance/Information exchange
  • Materials review and development
  • Collection, coordination, and distribution of Sickle Cell Service Demonstration Program data, best practices, and findings
  • Developing and sustaining partnerships
  • Reporting and dissemination of results

The Sickle Cell Service Demonstration Program is developing data collection tools that will include a final list of utilization questionnaires, data elements, indicators, measures and performance targets, and data forms.

Funding includes costs associated with grant reviews, processing of grants through the Grants Administration Tracking and Evaluation System (GATES) and HRSA’s electronic handbook, and follow-up performance reviews.

Funding History

FY 2004 ---
FY 2005 $ 198,000
FY 2006 $2,177,000
FY 2007 $2,180,000
FY 2008 $2,653,000

Budget Request
The FY 2009 request of $2,184,000 is a decrease of $469,000 from the FY 2008 Enacted level. Activities funded under this authority will address HRSA strategic goals 1, 2, 3, 4 and 5. In particular this program will address the elimination of health disparities for individuals with Sickle Cell Disease. The program will continue to address the priorities described above in the four year plan. The four year plan began in 2006 and will end in 2010. Over all, the program will facilitate the delivery of education, health promotion, patient and family support, state of the art treatment, and continuous, coordinated care to individuals with Sickle Cell Disease. In addition, the protocols and educational materials will facilitate the establishment of a uniform and quality approach to the care and treatment of individuals with Sickle Cell Disease. Funds are provided for pay related increases.

# Key Outputs FY 2004 Actual FY 2005 Actual FY 2006 FY 2007 FY 2008 Target/Est. FY 2009 Target/Est. Out-Year Target/ Est.
Target/ Est. Actual Target/ Est. Actual
  Grants       4   4 4 4 --
  National Coordinating Center       1   1 1 1 --
  Appropriated Amount ($ Million)       2.177   2.18 2.653 2.184